Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Fabrizio Schifano, G. Duccio Papanti, Laura Orsolini & John M. Corkery. (2016) Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. Expert Review of Clinical Pharmacology 9:7, pages 943-954.
Read now
Read now
Simon Gibbons. (2012) ‘Legal Highs’ – novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clinical Toxicology 50:1, pages 15-24.
Read now
Read now
Jonathan Ott. (2001) Pharmañopo—Psychonautics: Human Intranasal, Sublingual, Intrarectal, Pulmonary and Oral Pharmacology of Bufotenine. Journal of Psychoactive Drugs 33:3, pages 273-281.
Read now
Read now
MichaelC. McBride. (2000) Bufotenine: Toward an Understanding of Possible Psychoactive Mechanisms. Journal of Psychoactive Drugs 32:3, pages 321-331.
Read now
Read now
Lucía Moreira-Demarco, Paloma Alvarez-Blanco, Juan Pablo Llopart, Elena Angulo & Raúl Maneyro. Trophic ecology of juvenile amphibians: relative level of myrmecophagy in two anuran species. Studies on Neotropical Fauna and Environment 0:0, pages 1-17.
Read now
Read now
Articles from other publishers (46)
Stephan C. Tap. (2024)
The potential of 5‐methoxy‐
N,N
‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action
. Addiction Biology 29:4.
Crossref
Crossref
Rubi Barman, Pranjit Kumar Bora, Jadumoni Saikia, Parthapratim Konwar, Aditya Sarkar, Phirose Kemprai, Siddhartha Proteem Saikia, Saikat Haldar, Adrian Slater & Dipanwita Banik. (2024) Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans. Phytochemistry 218, pages 113928.
Crossref
Crossref
Omnia Yehia Farouk, John Refaat Fahim, Eman Zekry Attia & Mohamed Salah Kamel. (2023) Phytochemical and biological profiles of the genus Phragmites (Family Poaceae): A review. South African Journal of Botany 163, pages 659-672.
Crossref
Crossref
Ali Asghar Hakami Zanjani, Teresa Quynh Tram Nguyen, Luise Jacobsen & Himanshu Khandelia. (2023) The molecular basis of the antidepressant action of the magic mushroom extract, psilocin. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1871:4, pages 140914.
Crossref
Crossref
Francesco Gambassi, Cecilia Lanzi, Zaccaria Ricci, Pierpaolo Duchini, Manuela L'Erario, Guido Mannaioni, Nicoletta Cini, Alessandro Bonari, Claudia Saffirio & Brunella Occupati. (2022) Life-threatening pediatric poisoning due to ingestion of Bufo bufo toad eggs: A case report. Toxicon 217, pages 13-16.
Crossref
Crossref
Hannes M Schwelm, Nicole Zimmermann, Tobias Scholl, Johannes Penner, Amy Autret, Volker Auwärter & Merja A Neukamm. (2022)
Qualitative and Quantitative Analysis of Tryptamines in the Poison of
Incilius alvarius
(Amphibia: Bufonidae)
. Journal of Analytical Toxicology 46:5, pages 540-548.
Crossref
Crossref
Thomas P. Bambauer, Lea Wagmann, Armin A. Weber & Markus R. Meyer. (2021)
Further development of a liquid chromatography–high‐resolution mass spectrometry/mass spectrometry‐based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or
Ricinus communis
ingestions
. Drug Testing and Analysis 13:9, pages 1603-1613.
Crossref
Crossref
Yu Zai, Xinping Xi, Zhuming Ye, Chengbang Ma, Mei Zhou, Xiaoling Chen, Shirley W. I. Siu, Tianbao Chen, Lei Wang & Hang Fai Kwok. (2021) Aggregation and Its Influence on the Bioactivities of a Novel Antimicrobial Peptide, Temporin-PF, and Its Analogues. International Journal of Molecular Sciences 22:9, pages 4509.
Crossref
Crossref
Tehila Mishraki‐Berkowitz, Esti Kochelski, Pierce Kavanagh, John O'Brien, Clodagh Dunne, Brian Talbot, Patricia Ennis & Udi (Ehud) Wolf. (2020) The Psilocin (4‐hydroxy‐N,N‐dimethyltryptamine) and Bufotenine (5‐hydroxy‐N,N‐dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified. Journal of Forensic Sciences 65:5, pages 1450-1457.
Crossref
Crossref
Nathan D. Sepeda, John M. Clifton, Laura Y. Doyle, Rafael Lancelotta, Roland R. Griffiths & Alan K. Davis. (2020) Inhaled 5-methoxy-N,N-dimethyltryptamine: Supportive context associated with positive acute and enduring effects. Journal of Psychedelic Studies 4:2, pages 114-122.
Crossref
Crossref
Thomas R. Whyte & J. Matthew Compton. (2020) Explaining Toad Bones in Southern Appalachian Archaeological Deposits. American Antiquity 85:2, pages 305-330.
Crossref
Crossref
Robert Beckstead, Bryce Blankenagel, Cody Noconi & Michael Winkelman. (2019) The entheogenic origins of Mormonism: A working hypothesis. Journal of Psychedelic Studies 3:2, pages 212-260.
Crossref
Crossref
Matthew T. McElroyDavid A. Donoso. (2019) Ant Morphology Mediates Diet Preference in a Neotropical Toad (Rhinella alata). Copeia 107:3, pages 430.
Crossref
Crossref
Andrey Viktorovich Antsyborov & Irina Vladimirovna Dubatova. (2019) New psychoactive substances: psychiatrist's view. Interactive science:6 (40), pages 57-67.
Crossref
Crossref
Donna Nash & Susan D. deFrance. (2019) Plotting abandonment: Excavating a ritual deposit at the Wari site of Cerro Baúl. Journal of Anthropological Archaeology 53, pages 112-132.
Crossref
Crossref
M. Rosaria Varì, Simona Pichini, Raffaele Giorgetti & Francesco P. Busardò. (2018) New psychoactive substances—Synthetic stimulants. WIREs Forensic Science 1:2.
Crossref
Crossref
Joseph Barsuglia, Alan K. Davis, Robert Palmer, Rafael Lancelotta, Austin-Marley Windham-Herman, Kristel Peterson, Martin Polanco, Robert Grant & Roland R. Griffiths. (2018) Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study. Frontiers in Psychology 9.
Crossref
Crossref
Alan K Davis, Joseph P Barsuglia, Rafael Lancelotta, Robert M Grant & Elise Renn. (2018)
The epidemiology of 5-methoxy-
N, N
-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
. Journal of Psychopharmacology 32:7, pages 779-792.
Crossref
Crossref
Hugo Vigerelli, Juliana Mozer Sciani, Maria Andrea Camarano Eula, Luciana Almeida Sato, Marta M. Antoniazzi, Carlos Jared & Daniel C. Pimenta. (2018) Biological Effects and Biodistribution of Bufotenine on Mice. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
Joseph P. Barsuglia, Martin Polanco, Robert Palmer, Benjamin J. Malcolm, Benjamin Kelmendi & Tanya Calvey. 2018. Psychedelic Neuroscience. Psychedelic Neuroscience
121
158
.
Candelario Rodríguez, Louise Rollins-Smith, Roberto Ibáñez, Armando A. Durant-Archibold & Marcelino Gutiérrez. (2017) Toxins and pharmacologically active compounds from species of the family Bufonidae (Amphibia, Anura). Journal of Ethnopharmacology 198, pages 235-254.
Crossref
Crossref
Curtis P. Snook. 2017. Critical Care Toxicology. Critical Care Toxicology
1587
1607
.
Curtis P. Snook. 2016. Critical Care Toxicology. Critical Care Toxicology
1
22
.
Fabrizio Schifano, Laura Orsolini, Duccio Papanti & John Corkery. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
351
380
.
M. M. F. Queiroz, G. Marti, E. F. Queiroz, L. Marcourt, I. Castro-Gamboa, V. S. Bolzani & J.-L. Wolfender. (2015)
LC-MS/MS Quantitative Determination of
Tetrapterys mucronata
Alkaloids, a Plant Occasionally used in Ayahuasca Preparation
. Phytochemical Analysis 26:3, pages 183-188.
Crossref
Crossref
Leandro A. Moreira, Maria M. Murta, Claudia C. Gatto, Christopher W. Fagg & Maria L. dos Santos. (2015)
Concise Synthesis of
N,N
-Dimethyltryptamine and 5-Methoxy-
N,N
-dimethyltryptamine Starting with Bufotenine from Brazilian
Anadenanthera
ssp
. Natural Product Communications 10:4, pages 1934578X1501000.
Crossref
Crossref
Fabrizio Schifano, Laura Orsolini, G. Duccio Papanti & John M. Corkery. (2015) Novel psychoactive substances of interest for psychiatry. World Psychiatry 14:1, pages 15-26.
Crossref
Crossref
Margaret C. Hardy, Jonathon Cochrane & Rachel E. Allavena. (2014) Venomous and Poisonous Australian Animals of Veterinary Importance: A Rich Source of Novel Therapeutics. BioMed Research International 2014, pages 1-12.
Crossref
Crossref
Warunya Arunotayanun, Jeffrey W. Dalley, Xi-Ping Huang, Vincent Setola, Ric Treble, Leslie Iversen, Bryan L. Roth & Simon Gibbons. (2013) An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: Emerging ‘Novel Psychoactive Drugs’. Bioorganic & Medicinal Chemistry Letters 23:11, pages 3411-3415.
Crossref
Crossref
Rafaela Martin, Jennifer Schürenkamp, Angela Gasse, Heidi Pfeiffer & Helga Köhler. (2012) Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS. International Journal of Legal Medicine 127:3, pages 593-601.
Crossref
Crossref
Michael E. Peterson & Brian K. Roberts. 2013. Small Animal Toxicology. Small Animal Toxicology
833
839
.
Shaun L. Greene. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
363
381
.
Timothy J. Meehan, Sean M. Bryant & Steven E. Aks. (2010) Drugs of Abuse: The Highs and Lows of Altered Mental States in the Emergency Department. Emergency Medicine Clinics of North America 28:3, pages 663-682.
Crossref
Crossref
Rany Shamloul. (2010) Natural Aphrodisiacs. The Journal of Sexual Medicine 7:1_Part_1, pages 39-49.
Crossref
Crossref
Richard T. Tovar & Renee M. Petzel. (2009) Herbal Toxicity. Disease-a-Month 55:10, pages 592-641.
Crossref
Crossref
Alexei Y. Bagrov, Joseph I. Shapiro & Olga V. Fedorova. (2009) Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets. Pharmacological Reviews 61:1, pages 9-38.
Crossref
Crossref
Donald G. Barceloux. 2008. Medical Toxicology of Natural Substances. Medical Toxicology of Natural Substances
996
1007
.
Yu‐Yun Wang & Chinpiao Chen. (2007) Synthesis of a deuterium‐labelled standard of bufotenine (5‐HO‐DMT). Journal of Labelled Compounds and Radiopharmaceuticals 50:14, pages 1262-1265.
Crossref
Crossref
John C.M. Brust. 2007. Aspects neurologiques de l'addiction. Aspects neurologiques de l'addiction
315
334
.
Christian Moretti, Yvan Gaillard, Pierre Grenand, Fabien Bévalot & Jean-Michel Prévosto. (2006) Identification of 5-hydroxy-tryptamine (bufotenine) in takini (Brosimum acutifolium Huber subsp. acutifolium C.C. Berg, Moraceae), a shamanic potion used in the Guiana Plateau. Journal of Ethnopharmacology 106:2, pages 198-202.
Crossref
Crossref
Michael E. Peterson & Brian K. Roberts. 2006. Small Animal Toxicology. Small Animal Toxicology
1083
1093
.
John C.M. Brust. 2004. Neurological Aspects of Substance Abuse. Neurological Aspects of Substance Abuse
259
274
.
Stephen McClean, Robert C. Robinson, Chris Shaw & W. Franklin Smyth. (2002) Characterisation and determination of indole alkaloids in frog‐skin secretions by electrospray ionisation ion trap mass spectrometry. Rapid Communications in Mass Spectrometry 16:5, pages 346-354.
Crossref
Crossref
Alexei Y Bagrov, Yakov Y Bagrov, Olga V Fedorova, Vladimir A Kashkin, Nadezhda A Patkina & Edwin E Zvartau. (2002) Endogenous digitalis-like ligands of the sodium pump: possible involvement in mood control and ethanol addiction. European Neuropsychopharmacology 12:1, pages 1-12.
Crossref
Crossref
Paola Sandroni. (2001) Aphrodisiacs past and present: A historical review. Clinical Autonomic Research 11:5, pages 303-307.
Crossref
Crossref
Brian K. Roberts, Michael G. Aronsohn, Bradley L. Moses, Ronald L. Burk, Jeffrey Toll & F. Robert Weeren. (2000)
Bufo marinus
intoxication in dogs: 94 cases (1997–1998)
. Journal of the American Veterinary Medical Association 216:12, pages 1941-1944.
Crossref
Crossref